Principal Financial Group Inc. Buys 25,736 Shares of Delcath Systems, Inc. (NASDAQ:DCTH)

Principal Financial Group Inc. raised its position in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 28.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 115,183 shares of the company's stock after purchasing an additional 25,736 shares during the period. Principal Financial Group Inc. owned 0.36% of Delcath Systems worth $1,387,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of DCTH. Polar Asset Management Partners Inc. purchased a new position in Delcath Systems during the third quarter valued at approximately $1,594,000. Virtu Financial LLC purchased a new position in shares of Delcath Systems during the third quarter worth about $289,000. Baader Bank Aktiengesellschaft purchased a new position in shares of Delcath Systems during the fourth quarter worth about $204,000. Jane Street Group LLC purchased a new position in shares of Delcath Systems during the third quarter worth about $110,000. Finally, Barclays PLC purchased a new position in shares of Delcath Systems during the third quarter worth about $104,000. 61.12% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on DCTH. HC Wainwright boosted their price objective on Delcath Systems from $22.00 to $24.00 and gave the stock a "buy" rating in a report on Friday. Craig Hallum upped their price objective on Delcath Systems from $18.00 to $21.00 and gave the stock a "buy" rating in a report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $22.75.

Remove Ads

Delcath Systems Stock Down 1.7 %

Shares of NASDAQ DCTH traded down $0.22 during midday trading on Friday, reaching $13.00. The company had a trading volume of 390,635 shares, compared to its average volume of 327,140. Delcath Systems, Inc. has a one year low of $3.70 and a one year high of $16.97. The firm's fifty day moving average price is $14.42 and its 200-day moving average price is $11.69. The stock has a market cap of $415.66 million, a PE ratio of -9.63 and a beta of 0.82.

Delcath Systems (NASDAQ:DCTH - Get Free Report) last released its earnings results on Thursday, March 6th. The company reported ($0.11) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.01). The company had revenue of $15.10 million during the quarter, compared to the consensus estimate of $14.96 million. Delcath Systems had a negative net margin of 150.70% and a negative return on equity of 338.16%. During the same period last year, the firm posted ($0.48) EPS. As a group, equities research analysts expect that Delcath Systems, Inc. will post -0.79 EPS for the current year.

About Delcath Systems

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.